Generic placeholder image

Current Neuropharmacology

Editor-in-Chief

ISSN (Print): 1570-159X
ISSN (Online): 1875-6190

Perspective

Suicidality and Cannabidiol: Opportunities and Challenges

Author(s): Ehsan Moazen-Zadeh and Igor I. Galynker*

Volume 19, Issue 6, 2021

Published on: 15 October, 2020

Page: [733 - 735] Pages: 3

DOI: 10.2174/1570159X18666201015160417

Abstract

Cannabidiol (CBD) is gaining considerable attention in the research community with promising results in a variety of neuropsychiatric conditions. In particular, there are replicated findings for the therapeutic effects of CBD on psychotic and anxiety symptoms as well as substance use disorders, all of which are highly prevalent in patients who present with suicidality. Meanwhile, there has been a lack of suicide research on cannabidiol. This perspective provides an overview of the available evidence, potential reasons behind the halt in suicide research on cannabidiol, and recommendations for future investigations.

Keywords: Cannabidiol, cannabis, marijuana, suicide, adverse events, psychopharmacology.

Graphical Abstract


© 2024 Bentham Science Publishers | Privacy Policy